AAAAAA

   
Results: 1-19 |
Results: 19
Carboplatin skin testing: A skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy
Authors: Zanotti, KM Rybicki, LA Kennedy, AW Belinson, JL Webster, KD Kulp, B Peterson, G Markman, M
Citation: Km. Zanotti et al., Carboplatin skin testing: A skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy, J CL ONCOL, 19(12), 2001, pp. 3126-3129
The effect of radiation therapy on brain metastases from endometrial carcinoma: A retrospective study
Authors: Mahmoud-Ahmed, AS Suh, JH Barnett, GH Webster, KD Belinson, JL Kennedy, AW
Citation: As. Mahmoud-ahmed et al., The effect of radiation therapy on brain metastases from endometrial carcinoma: A retrospective study, GYNECOL ONC, 83(2), 2001, pp. 305-309
Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases
Authors: Shen, ZZ Wu, MZ Elson, P Kennedy, AW Belinson, J Casey, G Xu, Y
Citation: Zz. Shen et al., Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases, GYNECOL ONC, 83(1), 2001, pp. 25-30
Tumor distribution and survival in six patients with brain metastases fromcervical carcinoma
Authors: Mahmoud-Ahmed, AS Suh, JH Barnett, GH Webster, KD Kennedy, AW
Citation: As. Mahmoud-ahmed et al., Tumor distribution and survival in six patients with brain metastases fromcervical carcinoma, GYNECOL ONC, 81(2), 2001, pp. 196-200
What do you recommend for a patient with a Pap smear indicating atypical cells?
Authors: Kennedy, AW
Citation: Aw. Kennedy, What do you recommend for a patient with a Pap smear indicating atypical cells?, CLEV CLIN J, 67(9), 2000, pp. 610-611
Treatment of gynecologic cancers in pregnancy
Authors: Zanotti, KM Belinson, JL Kennedy, AW
Citation: Km. Zanotti et al., Treatment of gynecologic cancers in pregnancy, SEMIN ONCOL, 27(6), 2000, pp. 686-698
The society of gynecologic oncologists outcomes task force
Authors: Kennedy, AW Austin, JM Look, KY Munger, CB
Citation: Aw. Kennedy et al., The society of gynecologic oncologists outcomes task force, GYNECOL ONC, 79(3), 2000, pp. 379-398
Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy
Authors: Zanotti, KM Belinson, JL Kennedy, AW Webster, KD Markman, M
Citation: Km. Zanotti et al., Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy, GYNECOL ONC, 79(2), 2000, pp. 211-215
Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma
Authors: Kushner, DM Webster, KD Belinson, JL Rybicki, LA Kennedy, AW Markman, M
Citation: Dm. Kushner et al., Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma, GYNECOL ONC, 78(2), 2000, pp. 221-227
2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells
Authors: Kushner, DM Paranjape, JM Bandyopadhyay, B Cramer, H Leaman, DW Kennedy, AW Silverman, RH Cowell, JK
Citation: Dm. Kushner et al., 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells, GYNECOL ONC, 76(2), 2000, pp. 183-192
Surgical considerations in intraperitoneal chemotherapy
Authors: Wiper, DW Kennedy, AW
Citation: Dw. Wiper et Aw. Kennedy, Surgical considerations in intraperitoneal chemotherapy, CUR CLIN ON, 2, 2000, pp. 151-166
Human papillomavirus typing and the reduction of cervical cancer risk
Authors: Jin, XW Cash, J Kennedy, AW
Citation: Xw. Jin et al., Human papillomavirus typing and the reduction of cervical cancer risk, CLEV CLIN J, 66(9), 1999, pp. 533
Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors
Authors: Zanotti, KM Hart, WR Kennedy, AW Belinson, JL Casey, G
Citation: Km. Zanotti et al., Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors, INT J GYN P, 18(3), 1999, pp. 247-253
The use of paclitaxel and platinum-based chemotherapy in uterine papillaryserous carcinoma
Authors: Zanotti, KM Belinson, JL Kennedy, AW Webster, KD Markman, M
Citation: Km. Zanotti et al., The use of paclitaxel and platinum-based chemotherapy in uterine papillaryserous carcinoma, GYNECOL ONC, 74(2), 1999, pp. 272-277
Survival probability in ovarian clear cell adenocarcinoma
Authors: Kennedy, AW Markman, M Biscotti, CV Emery, JD Rybicki, LA
Citation: Aw. Kennedy et al., Survival probability in ovarian clear cell adenocarcinoma, GYNECOL ONC, 74(1), 1999, pp. 108-114
Plasmacytoma of the ovary: A case report and literature review
Authors: Emery, JD Kennedy, AW Tubbs, RR Castellani, WJ Hussein, MA
Citation: Jd. Emery et al., Plasmacytoma of the ovary: A case report and literature review, GYNECOL ONC, 73(1), 1999, pp. 151-154
Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers (vol 71, pg 77, 1998)
Authors: Wiper, DW Zanotti, KM Kennedy, AW Belinson, JL Casey, G
Citation: Dw. Wiper et al., Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers (vol 71, pg 77, 1998), GYNECOL ONC, 72(2), 1999, pp. 268-268
Screening for gynecologic cancer
Authors: Zanotti, KM Kennedy, AW
Citation: Km. Zanotti et Aw. Kennedy, Screening for gynecologic cancer, MED CLIN NA, 83(6), 1999, pp. 1467
Experience with platinum-paclitaxel chemotherapy in the initial managementof papillary serous carcinoma of the peritoneum
Authors: Kennedy, AW Markman, M Webster, KD Kulp, B Peterson, G Rybicki, LA Belinson, JL
Citation: Aw. Kennedy et al., Experience with platinum-paclitaxel chemotherapy in the initial managementof papillary serous carcinoma of the peritoneum, GYNECOL ONC, 71(2), 1998, pp. 288-290
Risultati: 1-19 |